Chad Messer

Stock Analyst at Lake Street

(0.83)
# 3,973
Out of 5,044 analysts
29
Total ratings
44.83%
Success rate
-15.01%
Average return

Stocks Rated by Chad Messer

Genelux
Oct 21, 2025
Initiates: Buy
Price Target: $16
Current: $7.64
Upside: +109.42%
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $79.92
Upside: +32.63%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4$75
Current: $5.72
Upside: +1,211.19%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $1.22
Upside: +473.77%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $6.66
Upside: +140.24%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.98
Upside: +528.14%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $16.39
Upside: +40.33%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.87
Upside: +916.04%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134$114
Current: $3.04
Upside: +3,650.00%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $74.44
Upside: -32.83%
Maintains: Buy
Price Target: $33$48
Current: $61.97
Upside: -22.54%
Maintains: Buy
Price Target: $33$30
Current: $40.08
Upside: -25.14%
Initiates: Buy
Price Target: $50
Current: $69.93
Upside: -28.50%
Maintains: Buy
Price Target: $31$29
Current: $11.14
Upside: +160.32%
Initiates: Buy
Price Target: $10
Current: $2.10
Upside: +376.19%
Maintains: Buy
Price Target: $95$86
Current: $73.57
Upside: +16.90%
Initiates: Buy
Price Target: $75
Current: $4.64
Upside: +1,516.38%
Maintains: Buy
Price Target: $35$44
Current: $11.90
Upside: +269.75%
Maintains: Buy
Price Target: $182$166
Current: $24.22
Upside: +585.38%
Maintains: Buy
Price Target: $15$18
Current: $3.09
Upside: +482.52%